VANCOUVER, British Columbia, March 25, 2020 (GLOBE NEWSWIRE) — via OTC PR WIRE — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”) 
CBJ Newsmakers